We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

AUTOBIO DIAGNOSTICS CO., LTD

Autobio Diagnostics Co., Ltd is a clinical diagnostics company specializing in research & development, production, ma... read more Featured Products: More products

Download Mobile App





Autobio Diagnostics Showcases Automated Microbial Identification and ID-AST Solutions at ECCMID 2022

By LabMedica International staff writers
Posted on 25 Apr 2022

Autobio Diagnostics Co. More...

, Ltd. (Zhengzhou, Henan, China) showcased its fully automated microbial identification and antibiotic susceptibility testing (ID-AST) solutions at this year’s ECCMID, the largest international meeting of clinical microbiologists and infectious diseases specialists.

At ECCMID 2022, Autobio demonstrated the AutoMic-I600 automated ID-AST system for quick and accurate microbial identification and ID-AST that supports automatic sample pipetting, incubation and detection. Five different antibiotic cards, including the most comprehensive antibiotic panels, help microbiologists to find out suitable antimicrobial treatment within much shorter time cost. It supports random placement of multiple varieties of board card along with bidirectional intelligent identification and matching of board card and specimen. With two determination methods (colorimetric and turbidimetric), and four wavelength detection, continuous automated interpretation, and AI algorithm model, the AutoMic-I600 ensures scientific and accurate results.

In addition, Autobio highlighted its MALDI-TOF MS (Matrix Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry) system for use in microbiological clinical laboratories for the identification of pathogenic bacteria, especially microaerobes, anaerobes, mycobacteria and fungi. Its powerful database includes more than 16,000 strains covering more than 5,000 species and 1000 genera along with a unique filamentous fungi database of more than 1,000 strains covering 450 +species and 70+ genera. Autobio’s MALDI-TOF MS system features a localized and updatable microbial strain database for high identification accuracy. Autobio also presented the AutoMimo system to improve pipetting efficiency and optimize workflow in the lab when conducting experiments with its MALDI TOF microbial identification system. The instrument is also compatible with MALDI TOF of other brands.

Related Links:
Autobio Diagnostics Co., Ltd. 


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Automated MALDI-TOF MS System
EXS 3000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The TmS computational biomarker analyzes tumor gene expression and microenvironment data to guide treatment decisions (Photo courtesy of MD Anderson Cancer Center)

New Biomarker Predicts Chemotherapy Response in Triple-Negative Breast Cancer

Triple-negative breast cancer is an aggressive form of breast cancer in which patients often show widely varying responses to chemotherapy. Predicting who will benefit from treatment remains challenging,... Read more

Industry

view channel
Image: The initiative aims to speed next-generation diagnostic development during early pathogen emergence (photo courtesy of 123RF)

Cepheid Joins CDC Initiative to Strengthen U.S. Pandemic Testing Preparednesss

Cepheid (Sunnyvale, CA, USA) has been selected by the U.S. Centers for Disease Control and Prevention (CDC) as one of four national collaborators in a federal initiative to speed rapid diagnostic technologies... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.